45 results
8-K
EX-10.1
IMPLQ
Impel Pharmaceuticals Inc
20 Dec 23
Impel Pharmaceuticals Announces Filing Voluntary Chapter 11 Cases and Signing of “Stalking Horse” Agreement to Facilitate Sale
6:08am
in ARTICLE 8 (excluding conditions that, by their terms, are to be satisfied at the Closing, but subject to the satisfaction or waiver of all such conditions … , executed by or on behalf of Purchaser as to the satisfaction of the conditions set forth in Section 8.3(a) and Section 8.3(b); and
(ii) payment
8-K
EX-10.1
IMPLQ
Impel Pharmaceuticals Inc
14 Nov 23
Departure of Directors or Certain Officers
4:01pm
of Payments.
(a) Subject to and contingent upon satisfaction of the conditions set forth in Section 5 above and the provisions of Section 9 below
424B5
IMPLQ
Impel Pharmaceuticals Inc
5 Oct 23
Prospectus supplement for primary offering
5:19pm
, satisfaction of minimum net revenue and product units sold covenants and satisfaction of certain other covenants and conditions specified … process milestones, satisfaction of minimum net revenue and product units sold covenants and satisfaction of certain other covenants and conditions
8-K
EX-10.1
IMPLQ
Impel Pharmaceuticals Inc
4 Oct 23
Entry into a Material Definitive Agreement
5:21pm
defined herein shall have the meanings assigned to such terms in the Existing Credit Agreement.
2.Amendments. Subject to the satisfaction … in principal amount of Tranche B Term Loans upon satisfaction of the Milestone required to be completed by October 6, 2023 (subject to satisfaction of all
8-K
sl05fn wc6y4f
4 Oct 23
Entry into a Material Definitive Agreement
5:21pm
8-K
EX-10.3
5r16auzhc4 4k23r
7 Sep 23
Entry into a Material Definitive Agreement
4:19pm
8-K
EX-10.1
fawmj53nrt
7 Sep 23
Entry into a Material Definitive Agreement
4:19pm
8-K
EX-10.2
26v7oj8x 7i72ou972gf
7 Sep 23
Entry into a Material Definitive Agreement
4:19pm
8-K
piqndxid57wo
7 Sep 23
Entry into a Material Definitive Agreement
4:19pm
8-K
EX-10.1
f10ydeie
21 Aug 23
Entry into a Material Definitive Agreement
8:33am
10-K/A
EX-3.2
suevz4fn ugm
31 Mar 23
Annual report (amended)
4:21pm
424B5
vzq0r79acuf1b2o
24 May 22
Prospectus supplement for primary offering
4:32pm
S-3
EX-1.2
0scfq3l2sps0 zks
16 May 22
Shelf registration
4:49pm
S-3
EX-4.4
q92 yhpjun10kq8
16 May 22
Shelf registration
4:49pm
S-3
9gij4i nice
16 May 22
Shelf registration
4:49pm